Evidence map›Paper›PMID 37466908›Full record

ArticleMycotoxin research2023

The nephrotoxin ochratoxin a impairs resilience of energy homeostasis of human proximal tubule cells.

Gerald Schwerdt, Michael Kopf, Michael Gekle

Open access · hybridAbstract read
In one paragraph

Article in Mycotoxin research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gerald SchwerdtJulius-Bernstein-Institut Für Physiologie, Martin-Luther-Universität Halle-Wittenberg, Magdeburger Str. 6, 06112, Halle, Germany. gerald.schwerdt@medizin.uni-halle.de.ORCID http://orcid.org/0000-0003-2644-3048
Michael KopfJulius-Bernstein-Institut Für Physiologie, Martin-Luther-Universität Halle-Wittenberg, Magdeburger Str. 6, 06112, Halle, Germany.
Michael GekleJulius-Bernstein-Institut Für Physiologie, Martin-Luther-Universität Halle-Wittenberg, Magdeburger Str. 6, 06112, Halle, Germany.
Martin Luther University Halle-Wittenberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite a long history of research, the mode of action of the mycotoxin ochratoxin A (OTA) is still not clear. Based on our observation that OTA-exposed cells consume more glucose and produce more lactate than control cells, with this study, we want to suggest another possible mode of action of OTA, involving cellular metabolism and mitochondria. We exposed human proximal tubule cells (HK2 cells) to OTA and studied its influence on mitochondrial performance as well as on the expression of energy homeostasis-involved routing proteins (AMPK and TXNIP) and on glucose transporting and metabolizing proteins. OTA reduced the capacity of mitochondria to increase their oxygen consumption rate forcing the cells to switch to the ineffective anaerobic glycolysis which demands higher glucose availability. The higher glucose demand is met by augmented cellular glycogen degradation and increased glucose uptake capabilities by increasing glucose transporter expression. We conclude that OTA exposure leads to impaired mitochondria, which forces the cells to alter their metabolism in order to ensure energy supply. We suggest to consider a possible effect of OTA on metabolism and mitochondria and to have a closer look on OTA-induced changes in the metabolome as possible additional players in OTA toxicity.

Indexed as

MycotoxinsOchratoxinsGlucoseHomeostasisHumansGlucoseMycotoxinsochratoxin AOchratoxinsEnergy metabolismGlucoseMitochondriaOchratoxin A

Identifiers

PMID37466908
PMCPMC10635976
OpenAlexW4384664091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.